NO953313L - Fremgangsmåte for fremstilling av (-)-N-metyl-N-[4-(4-fenyl-4-asetylaminopiperidin-1-yl)-2-(3,4-diklorfenyl)butylÅ benzamid og dets farmasöytisk akseptable salter - Google Patents

Fremgangsmåte for fremstilling av (-)-N-metyl-N-[4-(4-fenyl-4-asetylaminopiperidin-1-yl)-2-(3,4-diklorfenyl)butylÅ benzamid og dets farmasöytisk akseptable salter

Info

Publication number
NO953313L
NO953313L NO953313A NO953313A NO953313L NO 953313 L NO953313 L NO 953313L NO 953313 A NO953313 A NO 953313A NO 953313 A NO953313 A NO 953313A NO 953313 L NO953313 L NO 953313L
Authority
NO
Norway
Prior art keywords
preparation
benzamide
dichlorophenyl
phenyl
methyl
Prior art date
Application number
NO953313A
Other languages
English (en)
Other versions
NO953313D0 (no
NO305167B1 (no
Inventor
Marcel Descamps
Joel Radisson
Gilles Anne-Archard
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of NO953313D0 publication Critical patent/NO953313D0/no
Publication of NO953313L publication Critical patent/NO953313L/no
Publication of NO305167B1 publication Critical patent/NO305167B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/64—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having an aryl radical as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/22—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
    • C07C215/28—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/41—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by carboxyl groups, other than cyano groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO953313A 1994-08-24 1995-08-23 FremgangsmÕte for fremstilling av (-)-N-metyl-N-[4-(4-fenyl-4-acetylaminopiperidin-1-yl)-2-(3,4-diklorfenyl)butyl]benzamid og dets farmas°ytisk akseptable salter NO305167B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/294,035 US5512680A (en) 1993-02-26 1994-08-24 Process for the preparation of an optically pure aminoalcohol

Publications (3)

Publication Number Publication Date
NO953313D0 NO953313D0 (no) 1995-08-23
NO953313L true NO953313L (no) 1996-02-26
NO305167B1 NO305167B1 (no) 1999-04-12

Family

ID=23131621

Family Applications (1)

Application Number Title Priority Date Filing Date
NO953313A NO305167B1 (no) 1994-08-24 1995-08-23 FremgangsmÕte for fremstilling av (-)-N-metyl-N-[4-(4-fenyl-4-acetylaminopiperidin-1-yl)-2-(3,4-diklorfenyl)butyl]benzamid og dets farmas°ytisk akseptable salter

Country Status (24)

Country Link
US (2) US5512680A (no)
EP (1) EP0698601B1 (no)
JP (1) JP3037592B2 (no)
KR (1) KR100275978B1 (no)
AT (1) ATE172964T1 (no)
AU (1) AU685971B2 (no)
BR (1) BR9503776A (no)
CA (1) CA2156764C (no)
CZ (1) CZ289654B6 (no)
DE (1) DE69505756T2 (no)
DK (1) DK0698601T3 (no)
ES (1) ES2125574T3 (no)
FI (1) FI116221B (no)
HU (1) HU218485B (no)
IL (1) IL114866A (no)
MY (1) MY116365A (no)
NO (1) NO305167B1 (no)
NZ (1) NZ272827A (no)
PL (1) PL182914B1 (no)
RU (1) RU2097376C1 (no)
SI (1) SI0698601T1 (no)
SK (1) SK281454B6 (no)
TW (1) TW410223B (no)
ZA (1) ZA957025B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2792835B3 (fr) * 1999-04-27 2001-05-25 Sanofi Sa Utilisation du saredutant pour la preparation de medicaments utiles dans le traitement ou la prevention de l'ensemble des troubles de l'humeur, des troubles de l'adaptation ou des troubles mixtes anxiete-depression
WO2007020079A2 (en) * 2005-08-17 2007-02-22 Synthon B.V. Orally disintegratable simvastatin tablets
JP2009191006A (ja) * 2008-02-14 2009-08-27 Sumitomo Chemical Co Ltd 光学活性な４−アミノ−３−（３，４−ジクロロフェニル）ブタン−１−オールの製造方法およびその中間体
US20180208544A1 (en) 2015-07-13 2018-07-26 Piramal Enterprises Limited An improved process for the preparation of baclofen and its intermediate

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE903957A1 (en) 1989-11-06 1991-05-08 Sanofi Sa Aromatic amine compounds, their method of preparation and¹pharmaceutical compositions in which they are present
IL99320A (en) 1990-09-05 1995-07-31 Sanofi Sa Arylalkylamines, their preparation and pharmaceutical preparations containing them
FR2676054B1 (fr) 1991-05-03 1993-09-03 Sanofi Elf Nouveaux composes n-alkylenepiperidino et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2688219B1 (fr) 1992-03-03 1994-07-08 Sanofi Elf Sels d'ammonium quaternaires de composes aromatiques amines, leur preparation et compositions pharmaceutiques les contenant.
US5391819A (en) * 1992-09-30 1995-02-21 Merck & Co., Inc. Process of making chiral 2-aryl-1,4-butanediamine derivatives as useful neurokinin-A antagonists
FR2701946B1 (fr) * 1993-02-26 1995-05-24 Sanofi Elf Procédé pour la préparation d'un aminoalcool optiquement pur.

Also Published As

Publication number Publication date
EP0698601B1 (en) 1998-11-04
JP3037592B2 (ja) 2000-04-24
AU3021695A (en) 1996-03-07
CZ289654B6 (cs) 2002-03-13
CZ216495A3 (en) 1996-03-13
IL114866A0 (en) 1995-12-08
ZA957025B (en) 1996-03-26
CA2156764A1 (en) 1996-02-25
NO953313D0 (no) 1995-08-23
FI116221B (fi) 2005-10-14
SK103095A3 (en) 1996-03-06
FI953994A0 (fi) 1995-08-24
AU685971B2 (en) 1998-01-29
DE69505756D1 (de) 1998-12-10
JPH08176108A (ja) 1996-07-09
PL182914B1 (pl) 2002-04-30
PL310155A1 (en) 1996-03-04
RU2097376C1 (ru) 1997-11-27
IL114866A (en) 1999-12-22
KR100275978B1 (ko) 2000-12-15
US5512680A (en) 1996-04-30
DK0698601T3 (da) 1999-07-19
DE69505756T2 (de) 1999-05-27
HU9502481D0 (en) 1995-10-30
ATE172964T1 (de) 1998-11-15
FI953994A (fi) 1996-02-25
SK281454B6 (sk) 2001-03-12
US5780666A (en) 1998-07-14
HUT74184A (en) 1996-11-28
HU218485B (hu) 2000-09-28
ES2125574T3 (es) 1999-03-01
EP0698601A1 (en) 1996-02-28
CA2156764C (en) 2006-06-13
NZ272827A (en) 1997-11-24
KR960007562A (ko) 1996-03-22
MY116365A (en) 2004-01-31
SI0698601T1 (en) 1999-04-30
NO305167B1 (no) 1999-04-12
BR9503776A (pt) 1996-04-16
TW410223B (en) 2000-11-01

Similar Documents

Publication Publication Date Title
AU6255390A (en) New n-aryl and n-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme a: cholesterol acyl transferase
NO953313D0 (no) Fremgangsmåte for fremstilling av (-)-N-metyl-N-[4-(4-fenyl-4-asetylaminopiperidin-1-yl)-2-(3,4-diklorfenyl)butylÅ benzamid og dets farmasöytisk akseptable salter
HU9400001D0 (en) Nonateraenoic acid derivaties and process for producing them
AU2532692A (en) Method for treating hypertension
FI102748B1 (fi) Menetelmä N-(2,6-dialkyylifenyyli)-2-(2-okso-1-pyrrolidinyyli)asetamidijohdannaisen valmistamiseksi
AU5932394A (en) New compound, leustroducsin H, its preparation and its therapeutic use
CA2190858A1 (en) Intermediate for preparing a pharmaceutically active compound

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees